Communiqués Ventas, Inc.

Actions

VTR

US92276F1003

Sociétés de placement immobilier spécialisé

Marché Fermé - NYSE Autres places de cotation 22:00:02 26/06/2026			Varia. 5j.	Varia. 1 janv.
89,05 ^USD	+1,85%		+9,13%	+15,08%

22/06	Ventas, Inc. annonce la nomination d'Andrew L. Wattula au poste de vice-président exécutif, Outpatient Medical & Research, à compter d'août 2026	CI
18/06	VENTAS, INC. : Scotiabank n'est pas inspiré par le dossier	ZM

Communiqués

22/06	Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research	BU
03/06	Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement	BU
01/06	Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit’s REITweek 2026 Investor Conference	BU
13/05	Ventas Declares Quarterly Dividend of $0.52 Per Common Share	BU
27/04	Ventas: Q1 Earnings Snapshot	AQ
27/04	Ventas : First Quarter 2026 Press Release	PU
27/04	Ventas : First Quarter 2026 Supplemental Report	PU
27/04	Ventas Reports 2026 First Quarter Results	BU
02/04	Ventas Announces First Quarter 2026 Earnings Release Date and Conference Call	BU
02/03	Ventas Issues Investor Presentation for Upcoming Investor Conferences	BU
05/02	Ventas: Q4 Earnings Snapshot	AQ
05/02	Ventas : Fourth Quarter 2025 Supplemental Report	PU
05/02	Ventas Reports Fourth Quarter and Full Year 2025 Results, Provides 2026 Outlook and Increases Dividend	BU
21/01	Ventas Announces Tax Treatment of 2025 Distributions	BU
14/01	Ventas Announces Fourth Quarter 2025 Earnings Release Date and Conference Call	BU
10/12	Ventas Declares Quarterly Dividend of $0.48 Per Common Share	BU
09/12	Ventas : 2025 Nareit REITworld Conference	PU
05/12	Ventas to Participate in Investor Meetings at Nareit’s REITworld 2025 Annual Conference	BU
02/12	Ventas Announces Pricing of Senior Notes Offering	BU
18/11	Ventas Announces Planned Retirement of Peter J. Bulgarelli, EVP, Outpatient Medical and Research and CEO of Lillibridge Healthcare Services	AQ
17/11	Ventas Announces Planned Retirement of Peter J. Bulgarelli, EVP, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services	BU
29/10/25	Ventas : Third Quarter 2025 Supplemental Report	PU
29/10/25	Ventas: Q3 Earnings Snapshot	AQ
29/10/25	Ventas Reports 2025 Third Quarter Results	BU
24/10/25	Ventas : ESG Document(GRESB 2025)	PU